Hamilton, MI, United States of America

Frederick J Van Doornik

This inventor holds 1 USPTO granted patent. Top assignee: The Upjohn Co.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick J Van Doornik. Retrieved from https://idiyas.com/inventor/frederick-j-van-doornik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Frederick J Van Doornik

Introduction

Frederick J Van Doornik is a notable inventor based in Hamilton, MI (US). He has made significant contributions to the field of pharmaceuticals through his innovative work. His research focuses on the development of amino substituted steroids, which have potential therapeutic applications.

Latest Patents

Frederick J Van Doornik holds a patent for "Triazinylpiperazinyl steroids." This patent discloses amino substituted steroids that contain a 4-[1,3,5-triazin-2-yl]- or 4-[1,2,4-triazin-3-yl]-1-piperazinyl group. These compounds are attached to the terminal carbon atom of the C.sub.17-side chain and are useful as pharmaceutical agents for treating various medical conditions. He has 1 patent to his name.

Career Highlights

Frederick J Van Doornik has worked at The Upjohn Company, where he has contributed to the development of innovative pharmaceutical products. His work has been instrumental in advancing the understanding of steroid compounds and their applications in medicine.

Collaborations

Some of his notable coworkers include John M McCall and Donald E Ayer. Their collaborative efforts have further enhanced the research and development initiatives at The Upjohn Company.

Conclusion

Frederick J Van Doornik's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…